Raj Parekh
Clinical and Scientific Advisory Group
Clinical development
Capellabioscience
United Kingdom
Biography
Raj joined Advent Life Sciences in 2005, bringing over 20 years of experience as an entrepreneur and investor in the life sciences.Following its sale to UCB-Celltech, he became Chairman of Chroma Therapeutics and of Galapagos NV, and a Director of Celldex Therapeutics before joining Advent.He has served on the Board of several portfolio Companies including Thiakis, Avila, EUSA and Cellnovo.
Research Interest
Pharmaceutical Sciences
